Genetics and Weight Loss: Why It's Harder for Some
Cambridge scientist Dr Giles Yeo explains how over 1,000 genes influence appetite and weight. Discover why willpower isn't the full story and what you can control.
Cambridge scientist Dr Giles Yeo explains how over 1,000 genes influence appetite and weight. Discover why willpower isn't the full story and what you can control.
Novo Nordisk launches daily Wegovy weight-loss pill in the US. The UK regulator could approve it this year, offering a needle-free alternative. Discover the pricing and market impact.
A Cambridge professor reveals a common gene mutation makes people feel constantly hungry, hindering weight loss. Discover the science and why new drugs offer hope.
A landmark UK ban on TV and online ads for HFSS foods like sugary cereals and pizza is now in force. The government says it will prevent 20,000 childhood obesity cases. Read the full story.
Juan Pedro Franco, once weighing 92 stone, has died from a kidney infection in Mexico aged 41. Read the full story on his health struggles and global obesity crisis.
New research suggests the smell of fatty foods like bacon during pregnancy could predispose children to obesity. Learn about the study's findings and the implications for maternal nutrition.
New NHS data exposes a growing health crisis as West Midlands records highest childhood obesity rates in England, with nearly 1 in 3 Year 6 children clinically obese.
Groundbreaking research exposes how current food labelling systems are failing British consumers and contributing to rising obesity rates across the UK.
Exclusive analysis reveals England's escalating obesity epidemic with stark regional disparities and concerning patterns emerging across different demographic groups.
New CDC data reveals American obesity rates have hit unprecedented levels, while revolutionary GLP-1 medications like Wegovy and Zepbound show promising results in combating the epidemic.
Exclusive analysis reveals how Britain's growing obesity epidemic is pushing the NHS toward an impossible choice between routine care and weight-related treatments as waiting lists hit record highs.
Exclusive: British surgeons pioneer revolutionary robotic prostate procedures that take just 10 minutes, offering new hope for thousands stuck on NHS waiting lists. Discover how this medical breakthrough is transforming cancer care across the UK.
Harry Moseley's heartbreaking story highlights growing fears over NHS treatment delays as young father dies after multiple postponed appointments during pandemic.
Shocking new research reveals the UK's favourite smoothing hair treatment contains up to 5 times the legal formaldehyde limit, posing serious cancer risks to clients and stylists.
Groundbreaking research from Lund University shows obesity significantly increases risk for numerous cancers including leukaemia, thyroid and breast cancer, with UK health experts calling for urgent action.
Groundbreaking research exposes how obesity has become the primary driver behind rising cancer rates in older adults, with stark warnings for UK healthcare systems.
Groundbreaking research exposes Australia's alarming obesity divide, with detailed analysis revealing which suburbs are winning and losing the battle of the bulge.
New data reveals America's obesity epidemic has worsened dramatically, with 22 states reaching unprecedented levels. Health experts warn of severe consequences for healthcare systems and national wellbeing.
Groundbreaking research shows weight loss injections like Wegovy and Ozempic do more than help shed pounds - they're linked to significant reductions in premature death from cancer, heart disease and diabetes.
New medical research reveals the sobering reality for patients discontinuing popular weight loss injections like Ozempic and Wegovy, with most regaining significant weight within months.
Exclusive: Costco pharmacies begin selling revolutionary weight loss injections Wegovy and Ozempic at competitive prices, making groundbreaking treatments more accessible across Britain.
Broadmoor Hospital prescribes controversial weight-loss injections including Ozempic to dangerous criminals battling obesity, sparking ethical debate about taxpayer-funded treatments for serious offenders.
Groundbreaking new research reveals how medications like Ozempic, Wegovy, Mounjaro and Zepbound are creating unprecedented weight loss opportunities this autumn, potentially reshaping public health approaches to obesity nationwide.
Breakthrough research shows Mounjaro users lost significantly more weight than Wegovy patients in head-to-head comparison, potentially reshaping obesity treatment across the UK.
A woman's astonishing account reveals how dramatic weight loss transformed her social experience, exposing society's hidden bias toward thinner bodies and raising questions about 'pretty privilege'.
The NHS is poised to prescribe diabetes medication Mounjaro for weight loss in a groundbreaking move that could help millions of Britons struggling with obesity. Health Secretary Wes Streeting announces major expansion of weight management services.
Eli Lilly accuses the UK of having Europe's most challenging drug pricing system, threatening patient access to new medicines like Mounjaro amid ongoing NHS negotiations.
Exclusive investigation reveals the soaring financial and human cost of new obesity drugs. As millions rely on Wegovy and Ozempic, the NHS faces a multi-billion pound dilemma when patients stop treatment and weight returns.
New generation weight-loss medications are doing more than suppress appetite; they're fundamentally altering our psychological and emotional connections to eating, raising profound questions for individuals and society.
A major UK trial reveals the new semaglutide pill, a potential game-changer in obesity treatment, leads to significant weight loss, offering a powerful alternative to injections.